What is the target price for Titan medical?
Their forecasts range from $4.00 to $4.00. On average, they expect Titan Medical's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 608.0% from the stock's current price. View analysts' price targets for Titan Medical or view top-rated stocks among Wall Street analysts. Who are Titan Medical's key executives?
What is the ticker symbol for Titan medical?
Titan Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TMD." How do I buy shares of Titan Medical? Shares of TMD and other Canadian stocks can be purchased through an online brokerage account.
Is Titan medical efficiently growing its dividend?
Titan Medical does not have a long track record of dividend growth. In the past three months, Titan Medical insiders have not sold or bought any company stock. The P/E ratio of Titan Medical is -1.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Is Titan medical (TMDI) a good stock to buy?
The company was founded on July 28, 2008 and is headquartered in Toronto, Canada. Is Titan Medical Inc. (TMDI) A Good Stock To Buy? Titan Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is Titan Medical stock a buy?
The 2 analysts offering 12-month price forecasts for Titan Medical Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +362.96% increase from the last price of 0.54.
Why is Titan Medical stock dropping?
Titan Medical (TSX:TMD) shares lost nearly half their value this morning after the medical device company suspended the timeline for its Sport robot-assisted surgery device.
Is Medtronic buying Titan Medical?
Robotic-assisted surgery company Titan Medical (Nasdaq: TMDI; TSX: TMD) is deepening its relationship with Medtronic (NYSE:MDT), securing a $2.6 million purchase order from the medtech giant.
What happened to Titan Medical?
Titan Medical's (TMDI -6.0%) stock fell following its FY21 results. For full year 2021, research and development expenses (R&D) rose to $37.9M, compared to $7.9M in 2020.
Is TMDI stock a buy right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 ho...
How has Titan Medical's stock price performed in 2022?
Titan Medical's stock was trading at $0.6251 at the start of the year. Since then, TMDI stock has decreased by 18.9% and is now trading at $0.5070....
Are investors shorting Titan Medical?
Titan Medical saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 412,700 shares, a drop of 21....
When is Titan Medical's next earnings date?
Titan Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for Tita...
How were Titan Medical's earnings last quarter?
Titan Medical Inc. (NASDAQ:TMDI) posted its quarterly earnings results on Thursday, March, 24th. The company reported ($0.02) earnings per share fo...
Who are Titan Medical's key executives?
Titan Medical's management team includes the following people: Mr. Paul G. Cataford B.Sc. , M.B.A., Chairman, Interim CEO & Pres (Age 58, Pay $3...
Who are some of Titan Medical's key competitors?
Some companies that are related to Titan Medical include OraSure Technologies (OSUR) , Accuray (ARAY) , InfuSystem (INFU) , InfuSystem (INFU) ,...
What other stocks do shareholders of Titan Medical own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Titan Medical investors own include NIO (NIO) , Advanced...
What is Titan Medical's stock symbol?
Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."
About Titan Medical
Titan Medical (NASDAQ:TMDI) Frequently Asked Questions
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation.
Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing ..
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Titan Medical stock. View analyst ratings for Titan Medical or view top-rated stocks.
Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic
TORONTO-- (BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access rob...
Titan Medical Selects Benchmark to Manufacture Enos Robotic Single Access Surgical System
TORONTO-- (BUSINESS WIRE)--Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic
Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference
TORONTO-- (BUSINESS WIRE)--Titan Medical Selects Benchmark to Manufacture Enos Robotic Single Access Surgical System
Titan Medical Completes Final Milestone Under Development Agreement with Medtronic
TORONTO-- (BUSINESS WIRE)--Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference
Titan Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
TORONTO-- (BUSINESS WIRE)--Titan Medical Completes Final Milestone under Development Agreement with Medtronic
Titan Medical Reports Third Quarter 2021 Financial Results
TORONTO-- (BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of an innovative single access robotic-assisted surge...
Headlines
TORONTO-- (BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on the development and commercialization of its innovative surgical technologies for robotic-a...
Titan Medical (TSE:TMD) Frequently Asked Questions
AlphaCentric Robotics and Automation Fund Buys ABB, Vuzix Corp, PROCEPT BioRobotics Corp, Sells ...
What is Titan Medical?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Titan Medical stock. View analyst ratings for Titan Medical or view top-rated stocks.
When will Titan Medical issue its results?
(Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces financial results for the three months ended March 31, 2021. During the first quarter of 2021 the company raised proceeds of $34.5 million from two equity financings and $10 million from the exercise of warrants issued to investors in previous offerings. Titan also announces changes to its board of directors appointing Paul Cataford as Chairman of the Board and Heather Knight as an independent member of the board. In addition, Cathy Steiner has been nominated for election to the Board at the annual and special meeting of shareholders on June 9, 2021.
When is Titan's Annual Meeting 2021?
("Titan" or the "Company") (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that the Company plans to issue its first quarter financial results prior to market opening Monday, May 17, 2021 and management will host an investor audio webcast at 4:30 p.m. ET to discuss financial results and business highlights. Speakers will include David J. McNally, President and Chief Executive Officer, Monique L. Delorme, Chief Financial Officer, and Perry A. Genova, Ph.D., Senior Vice President, Research and Development.
Is Titan Spine Medtronic?
(Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the voting results from the company’s Annual and Special Meeting of its Shareholders held on Wednesday, June 9, 2021 .
Who is the chairman of Titan?
For clarity, these agreements are between Medtronic and Titan Medical Inc., and Titan Medical is not affiliated with Titan Spine, which Medtronic acquired in 2019. About Titan Medical Inc. Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company headquartered in Toronto, Ontario and with R&D facilities in Chapel Hill, North Carolina, ...
Does Titan use Enos?
Titan also announces changes to its board of directors appointing Paul Cataford as Chairman of the Board and Heather Knight as an independent member of the board. In addition, Cathy Steiner has been nominated for election to the Board at the annual and special meeting of shareholders on June 9, 2021.
